MRP8 and MRP14 are two Ca2+-binding proteins of the S-1 00 family expressed by myelomonocytic cells. Both proteins assemble to noncovalently associated complexes in a Ca2+-dependent manner. Members of the S-I 00 family are known to play a role in cytoskeletal-membrane interactions; therefore, we investigated the subcellular distribution of MRP8/MRP14 and their complexes in human monocytes. Using differential centrifugation and subsequent Western blot or enzyme-linked immunosorbent assay analysis, we found that MRP8/MRP14 were almost completely translocated from the cytoplasma to membrane and cytoskeletal structures in a Ca2+-dependent manner. Using a cross-linking technique, complexed forms of MRP8/MRP14 were found to be associated with the plasma membrane. Analysis of MRP-transfected L132 RP8 AND MRP14 are two Ca2+-binding proteins of M the S-100 protein family.'.' Both proteins are expressed during myelomonocytic differentiation.'^^,^ They are present at high concentrations in granulocytes and monocytes, but are absent in lymphocytes. In contrast to granulocytes, expression of MRP8 and MRP 14 is downregulated during maturation of peripheral blood monocytes to macrophages in culture.l,3*4 Accordingly, the promyelocytic leukemia cell line HL-60 expressed MRP8/MRP14 when differentiated along the granulocytic pathway, whereas MRP8/MRP I4 disappeared when HL-60 cells were induced to differentiate to macrophagess In vivo, infiltrating monocytes express MRP8 and MRP14 in a variety of inflammatory disorders, whereas resident tissue macrophages do not possess these proteins at all.396-9 Synonyms for MRP8/MRP 14 are cystic fibrosis antigen, calgranulin a and b, p8 and p14, LI heavy and light chain, or calprotectin, re~pectively.~-'~ MRP8 and MRP14 are known to form noncovalently linked protein complexes with each other in a Caz+-dependent manner. Is The complexes of MRPS and MRP14, but not their monomers, have been described to inhibit the activity of casein kinases I and I1 in vitroI6J7 indicating their involvement in the network of intracellular signaling. Other members of the S-100 protein family have been reported to inhibit phosphorylation reactions of cytoskeleton-associated proteins (eg, S-100 a and S-100 fl)'8,'9 and to modulate cytoskeletal-membrane interactions (eg, calpactin).'~"'' So far, the interaction of MRP8/MRP14 with subcellular components of membrane and cytoskeletal structures has gained little attention. Recently, Bhardwaj et aIz3 showed association of a MRP8/MRPI 4 heterodimer to the cell membrane by flow cytometric surface analysis. However, in previous studies, MRP8 and MRP 14 have predominantly been described as cytoplasmatic protein^.'^,^^,^^ Because the influence of cellular Caz+ concentrations has been neglected in these studies, we analyzed the subcellular distribution of MRP8 and MRP14 and their complexed forms in dependence on Ca2+ levels. We now show that, with increasing Ca'+ concentrations, MRP8 and MRP14 are translocated to cells showed that the M R P I as well as the MRP14 component of the MRP8/MRP14 complex may independently bind to membrane and cytoskeletal structures. Furthermore, immunogold electron microscopy showed a colocalisation of MRP8/MRPI 4 and the intermediate filament type Ill protein vimentin in A231 87-treated monocytes. Our data indicate that, in analogy to other S -I 00-like proteins, M R P I and MRP14 play a role in Ca2+-dependent cytoskeletal-membrane interactions. Restriction of MRP8/ M R P l 4 expression to distinct stages of myelomonocytic differentiation suggests that these proteins are involved in highly specific pathways of intracellular signaling in phagocytes.
M the S-100 protein family.'.' Both proteins are expressed during myelomonocytic differentiation.'^^,^ They are present at high concentrations in granulocytes and monocytes, but are absent in lymphocytes. In contrast to granulocytes, expression of MRP8 and MRP 14 is downregulated during maturation of peripheral blood monocytes to macrophages in culture.l,3*4 Accordingly, the promyelocytic leukemia cell line HL-60 expressed MRP8/MRP14 when differentiated along the granulocytic pathway, whereas MRP8/MRP I4 disappeared when HL-60 cells were induced to differentiate to macrophagess In vivo, infiltrating monocytes express MRP8 and MRP14 in a variety of inflammatory disorders, whereas resident tissue macrophages do not possess these proteins at all.396-9 Synonyms for MRP8/MRP 14 are cystic fibrosis antigen, calgranulin a and b, p8 and p14, LI heavy and light chain, or calprotectin, re~pectively.~-'~ MRP8 and MRP14 are known to form noncovalently linked protein complexes with each other in a Caz+-dependent manner. Is The complexes of MRPS and MRP14, but not their monomers, have been described to inhibit the activity of casein kinases I and I1 in vitroI6J7 indicating their involvement in the network of intracellular signaling. Other members of the S-100 protein family have been reported to inhibit phosphorylation reactions of cytoskeleton-associated proteins (eg, S-100 a and S-100 fl)'8, '9 and to modulate cytoskeletal-membrane interactions (eg, calpactin).'~" '' So far, the interaction of MRP8/MRP14 with subcellular components of membrane and cytoskeletal structures has gained little attention. Recently, Bhardwaj et aIz3 showed association of a MRP8/MRPI 4 heterodimer to the cell membrane by flow cytometric surface analysis. However, in previous studies, MRP8 and MRP 14 have predominantly been described as cytoplasmatic protein^.'^,^^,^^ Because the influence of cellular Caz+ concentrations has been neglected in these studies, we analyzed the subcellular distribution of MRP8 and MRP14 and their complexed forms in dependence on Ca2+ levels. We now show that, with increasing Ca'+ concentrations, MRP8 and MRP14 are translocated to the cytoskeleton as well as to the plasma membrane which refers to their site of function.
MATERIALS AND METHODS
Cell culture. Monocytes were isolated from human buffy coats by Ficoll-Paque (Pharmacia, Freiburg, Germany) and subsequent Percoll (Pharmacia) density gradient centrifugation. Purity of monocytes was greater than 90% as determined by flow cytometric analysis using monoclonal antibodies (MoAbs) against CD14, CD15, and CD16.6 Cells were cultivated in Teflon bags (Biofolie 25; Heraeus Instruments, Hanau, Germany) using McCoy's 5A medium supplemented with 20% human serum for 1 day as described earlier! In some experiments, intracellular Caz+ levels were elevated by adding Ca" ionophore A23 187 (Sigma, Deisenhofen, Germany) to a final concentration of 10 pmol/L for 1 hour.
Antibodies. Monospecific affinity-purified rabbit antisera against human recombinant MRP8 and MRP14 (aMRP8 and aMRP14) were prepared as d e~c r i b e d . '~~* '~.~~ Mouse MoAbs 8-5C2 (S36.48) and biotinylated MoAbs S13.67 (S32.2) against MRP8 (MRP14) were provided by Dr G. Burmeister (Biomedicals AG, Augst, Switzerland). None of these antibodies showed cross-reactivity as tested by Western blotting of recombinant MRP8 and MRP14. For detection of cytoskeletal proteins, mouse MoAb V9 (Dianova, Hamburg, Germany) and a rabbit antiserum against the intermediate filament vimentin (Euro-Diagnostics, Appeldorn, The Netherlands), antisera against actin, actinin, tropomyosin, mi-crotuble-associated proteins (all obtained from Sigma), as well as MoAb My-21 against myosin, MoAb TKB 2.1 against @-tubulin (both purchased from Sigma), and an MoAb against a-tubulin (Amersham, Braunschweig, Germany) have been used. All antibodies were tested on cytospin preparations of monocytes of culture day I by immunoperoxidase staining before application for immunoelectron microscopy procedures. For control experiments, mouse IgG (Dianova) and rabbit IgG (Calbiochem, Bad Soden, Germany) of irrelevant specificity were used. Unless stated otherwise, antibodies were used at a concentration of I pg/mL.
Affinity-purified goat-antimouse and goat-antirabbit second stage antibodies, either peroxidase, phosphatase, or gold-(particle size 10 or 18 nm) conjugated, were obtained from Dianova and Amersham, respectively.
Transfections. The human embryonic lung cell line L132, transfected with MRPS, MRP14, or both MRP8/MRP14 cDNA by calcium phosphate precipitati~n?~ was kindly provided by Dr J. Briiggen, Ciba-Geigy, Basel, Switzerland. Briefly, L 132 were transfected with plasmids pCMVeMRP8 and pCMVeMRP14. A plasmid encoding neomycin resistance was cotransfected to allow selection of stable transfections with geneticin. Drug-resistant subclones were expanded and analyzed for expression of MRPS and MRP14 by an immunoperoxidase technique' using monospecific antisera.
Subcellularfractionation. For subcellular fractionation, I X 10" cells, monocytes, and transfected L 132 cells were harvested, washed three times in cold phosphate-buffered saline (PBS), pH 7.5, resuspended in 2 mL 20 mmol/L HEPES, pH 7.5, 2 mmol/L phenylmethylsulfonyl fluoride (PMSF) (= buffer 1) containing Ca2' concentrations varying between 100 pmol/L and 10 nmol/L or I mmol/L EGTA. Cells were subsequently homogenized by sonication with a Branson sonifier 250 (5 cycles, 50%, intensity 5) (Branson Ultrasonics, Danbury, CT). All following steps were performed at 4°C at Ca2+ and EGTA levels as described above. Isolation of membrane and cytoskeletal proteins was performed by differential centrifugation as described earlier.26,27 To obtain the cytoskeletal fraction, cellular homogenates were centrifuged at 1,OOOg for 10 minutes. Pellets were then washed three times in buffer 1 containing 1% NP40 and sonicated as described above. Pellets were lyophilized, weighed and resuspended in 8 mol/L urea, 50 mmol/L Tris, l mmol/L EGTA, 0.2% mercaptoethanol, 1 mmol/L PMSF. The I,OOOg supernatants were centrifuged at 10,OOOg for 30 minutes to remove cellular organelles like mitochondria, lysosomes and their fragments, or aggregated membrane sheets. The supernatant was then centrifuged at 100,OOOg for 1.5 hours (cytoplasmatic fraction) and stored at -80°C. The 100,OOOgpellet (membrane fraction) was washed two times in 5 mmol/L HEPES/2 mmol/L PMSF and centrifuged for 1 hour at 100,OOOg to release intravesicular enclosed cytoplasmatic proteins by osmotic shocks. Membrane pellets were resuspended in PBS containing 1% sodium dodecyl sulfate (SDS). Protein concentrations were determined using the BCA protein assay reagent (Pierce/KMF, Koln, Germany). To exclude contamination of membrane and cytoskeleton fractions by cytoplasmatic proteins, lactic dehydrogenase (LDH) activity was determined during the ultimate washing step of subcellular fractionation." Lactate dehydrogenase (LDH) activity was found to be less than 0. I% of its cytoplasmatic concentration in all membrane and cytoskeleton samples investigated. To study the reversibility of MRP8/ MRPl4-binding to membranes or cytoskeletal structures, monocytes were homogenized as described above using 100 pmol/L CaZ+ in buffer 1. Cytoskeleton and membrane pellets were then washed three times in the presence of 1 mmol/L EGTA or 10 mmol/L dithiothreitol (DTT) as described above.
Cross-linking experiments. Cross-linking of plasma membrane-associated MRP8/MRP I4 complexes was performed using BS3 (bis(sulfosuccinimidy1)suberate) (Pierce) or its lipophilic analogue DSS (disuccinimidylsuberate) (Pierce) according to StarosZ9 and Tsudo et al." Monocytes cultured for 1 day were stimulated with 10 pmol/L A23 187 for 1 hour and washed three times in cold PBS. Cells were incubated in PBS ( I X io6 cells/mL) containing 1 mmol/L BS3 or 1 mmol/L DSS for 20 dihutes at 4°C. Cross-linking reactions were stopped by washing with cold Tris-buffered saline (TBS) and viability of monocytes determined by trypan bluestaining. Cells were lysed in PBS containing I% NP40 and cell debris removed by centrifugation at l0,OOOg for 10 minutes.
Immunostaining of MRPS/MRPI 4 on Western blots. Cytoplasma and cytoskeletal fractions obtained by differential centrifugation as well as extracts of cross-linking experiments were separated by 15% SDS-polyacrylamide gel electrophoresis (PAGE)" under reducing conditions. Membrane fractions were analyzed according to the method of S c h m e r and von Jagow" under reducing conditions as well. Proteins were transferred onto polyvinylidene difluoride membranes (Immobilon P Millipore, Eschborn, Germ a n~) . '~ Blots were then immunostained with aMRP8 or aMRP14 which were subsequently detected by phosphatase-conjugated second stage antibodies as described earlier. 15 Enzyme-linked immunosorbent assays (ELISAs) for MRP8 and MRPI4. Maxi Sorb immunoplates (96-well; Nunc, Wiesbaden, Germany) were coated with MoAbs against MRPS (8-5C2) or MRP14 (S36.48) (300 ng/well) in 0.05 Na2C03, pH 9.5. All incubation steps were performed at 37°C for 1 hour. Nonspecific binding of proteins was inhibited by incubation with PBS, 0.1% Tween 20.
Samples diluted in PBS were allowed to react with the immobilized antibody. The ELISA was calibrated with recombinant MRP8 and MRP14 in concentrations ranging from 1 to 1,000 ng/mL. After extensive washing, 1 pg/mL biotinylated MoAb against MRP8 (S13.67) or MRP14 (S32.2) was added and subsequently detected by streptavidin-peroxidase conjugate (Extravidin; Sigma, 1 :20,000 in PBS, 0. I% Tween 20) using 2.2' azino-di-(3-ethyl-benzthiazoline-6-sulfonate) and H202 as substrates.
Because of limited solubility of cytoskeletal components, the MRP8/ MRP14 content of cytoskeletal fractions could not be determined by ELISA. Therefore, a quantitative dot-immunobinding assay was used essentially according to the method described by Jahn et al. 34 Briefly, samples (5 pg protein and dilutions from 1:2 up to 1: 128) of cytoplasmatic and cytoskeletal fractions were dot-blotted on nitrocellulose filters (Schleicher and Schiill, Dassel, Germany) using a Minifold I dot blotter (Schleicher and Schiill). Membranes were subsequently stained with primary antibodies (aMRP8 or aMRP14) as described above and then incubated with 150,000 cpm/mL "S-protein A (Amersham; specific activity, 24.6 TBq/ mmol/L) for 1 hour at 20°C. After thorough washing, membranes were dried, cut, and assayed for radioactivity in a liquid scintillation counter (LKB Pharmacia, Freiburg, Germany). Data obtained were linear over a range of about 2 to 50 ng MRP/dot. Reported data were derived solely from dilutions that were in these linear ranges.
Monocytes cultured for 24 hours either untreated or treated with A23187 for 1 hour were washed and fixed in 2% paraformaldehyde, 75 mmol/L lysin, and 7.5 mmol/L sodiumperiodate in phembuffer containing 60 mmol/ L 1,4-piperazinediethanesulfonic acid (PIPES), 25 mmol/L HEPES, 2 mmol/L MgC1;5 for I hour at 4°C. Cells were embedded in 10% gelatine, fixed a second time as described above, and treated with 15% polyvinylpyrrolidone 10,000 (Sigma) and 2.0 mol/L sucrose for 50 minutes. Then a cryoultramicrotomy procedure was used that was essentially similar to that described by Tokuya~u.'~ Briefly, samples were rapidly frozen in liquid N, and ultrathin cryosections obtained with a Reichert-Jung Ultracut E-FC4E cryomi-
Quant$cation of MRPS/MRP14 in cytoskeletal fractions.

Immunoelectron microscopy (IEM).
For personal use only. crotome (Reichert-Jung, Heidelberg, Germany) at -120°C. Aldehyde groups were quenched by 0.2% glycine in PBS. After blocking of nonspecific binding by 10% normal goat serum, primary antibodies were allowed to react with their antigens; subsequentlygold-conjugated secondary antibodies were allowed to react; both incubations were camed out at room temperature for 1 hour. For double-labeling experiments sections were incubated with either aMRP8 (aMRP14) followed by MoAb V9 against vimentin or a mouse MoAb against MRP8/MRP14 followed by a-vim. Primary antibodies were subsequently detected by goat-antirabbit IgG-gold (10 nm) or goat-antimouse IgG-gold ( 1 8 nm) complexes. The specificity of the immune reaction was controlled by replacement of each specific antibody by species-and isotype-matched control antibodies of irrelevant specificity. Sections were subsequently contrasted by 2% uranyloxalate and 2% uranylacetate for each 10 minutes. Finally, sections were embedded in 1% polyvinyl alcohol 10 , OOO (Sigma) and analyzed using a Philips CM 10 electron microscope (Philips, Eindhoven, The Netherlands).
RESULTS
Influence of Cd+ on the subcellular distribution ofMRP8
and MRPl4. Monocytes were purified from buffy coats and cultured for 1 day. Subcellular fractionation was performed using different Ca2' concentrations (100, I, 0.01 pmol/L Ca2', 1 mmol/L EGTA). Using SDS-PAGE under reducing conditions and Western blot technique, we found that MRP8 and MRP14 increasingly bind to membrane (100,OOOg pellet) and cytoskeletal (1,OOOg pellet) fractions with higher Ca2+ concentrations, whereas the level of these proteins in the cytoplasma fraction (100,OOOg supernatant) decreased (Fig I) .
To investigate the reversibility of this Ca2+-dependent binding of MRP8 and MRP14 to cytoskeletal and membrane structures, monocytes were fractionated in the presence of 100 pmol/L Ca2+. Membrane and cytoskeletal pel- 
-
lets were subsequently washed three times with buffers containing 1 mmol/L EGTA before SDS-PAGE and Western blotting. Because both MRP8 and MRP14 possess a free cystein group, which may be responsible for the association with specific membrane and cytoskeletal ligands, 10 mmol/ L DTT was added to all samples in a parallel experiment to reduce potential disulfide bridges. In both membrane and cytoskeletal fractions, the MRP8 and MRP14 content could be decreased by washing with EGTA, whereas DTT showed no effect at all (Fig 2) .
Quantification of MRP8/MRP14 in subcellular fractions. MRP8/MRPI 4 concentrations in cytoplasma and membrane fractions were measured using a sandwich-ELISA, cytoplasma, and cytoskeletal fractions by a quantitative dot-immunobinding assay using "S-protein A. MRP8 and MRP14 portions in these subcellular fractions and their dependency on Ca2+ levels are shown in Table 1 . Cytoskeletal data were related to those from dot blots of corresponding cytoplasma fractions whose MRP8/MRP14 content had simultaneously been determined by ELISA. Thus, data obtained by the two assay systems could be compared with each other. Comparing the MRP8/MRP14 content of each fraction with the ratio between the protein amount of each fraction and that of the entire cell the percentage of MRP8/MRP14 in each fraction could be estimated. As shown in Table I , considerable amounts of MRP8 and MRP14 were to be translocated to membrane and cytoskeletal structures in the presence of high Ca2+ levels. Interestingly, a higher amount of MRP 14 than of MRP8 was found to be associated to membranes, whereas MRP8 was quantitatively more detectable in the cytoskeletal fraction than MRP14.
To verify the cytoskeletal association of MRP8/MRP14 by a second method, an imImmunoelectron microscopy. munogold electron microscopy technique was used. In unstimulated monocytes, immunogold particles labeling MRP8 and MRP14 were dispersed all over the cytoplasma (Fig 3A) . The staining pattern of aMRP8 and aMRP14 in monocytes treated with 10 pmol/L of ionophore A23187 for 1 hour before IEM differed markedly. Analysis of the latter cells showed a translocation of MRP8 and MRP14 to the plasma membrane ( Fig 3B) (Fig 4A) .
Westem blot analysis showed a Ca*+-dependent association of both MRP8 and MRP14 to membrane and cytoskeletal fractions that was analogous in single-as well as in doubletransfected L132 cells (Fig 4B) .
Cross-linking studies. We then evaluated which MRP8/ MRP14 complexes were associated with the plasma membrane. Membrane proteins of viable monocytes were crosslinked using either BS3 or its lipophilic analogue DSS after stimulation with 10 pmol/L A23 187 for 1 hour. More than 95% of monocytes were viable after cross-linking as determined by trypan-blue staining. Cells were lysed and MRP8/ MRPl4 containing protein complexes were detected by MRP content in cytoplasmatic and membrane fractions determined by ELISA is presented in ng MRP/mg total protein of the fraction; MRP content in cytoplasmatic and cytoskeleton fractions obtained in parallel by a dot-immunobinding assay is shown as cpm/pg total protein of the fraction. Data are presented as mean f SD of five independent experiments; differences between Cat+ and EGTA values are statistically significant for each fraction (P 5 0 1 , Wilcoxon test). Additionally, the amount of MRP8/MRP14 in each fraction has been compared with total cellular MRP8/MRP14 content; values are expressed as percentage of total MRP8/MRP14 content. In the right column, amounts of protein in each fraction are compared with amounts of total cellular protein; values are expressed as percentage of total cellular protein.
Cytoskeleton
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From For
4-. Western blot technique. The lipophilic cross-linker DSS stabilized complexed forms of MRP8 and MRP14 with apparent molecular weights of about 25 Kd, 35 Kd, and, to a lesser extent, of 48 Kd, thus indicating that complexes of MRP8/MRP14 were associated with the plasma membrane (Fig 5) . Similar results were obtained when purified membrane fractions of monocytes were cross-linked (data not shown). BS3, which is hydrophilic, failed to stabilize membrane-associated complexes of MRP8 and MRP 14. Addition of dimethyl sulfoxide (DMSO), which was used to dissolve DSS, to BS3 had no effects regarding the complex pattern (Fig 5) . Similarly, parallel immunostaining for LDH of blots obtained from viable DSS-treated cells showed no cross-linked LDH complexes. In contrast, treatment of cell lysates with DSS led to stabilization of complexed LDH forms (data not shown). Therefore, we conclude that crosslinking of cytoplasmatic proteins did not occur after DSStreatment of viable cells, thus confirming the membrane origin of stabilized MRP8/MRP14 complexes.
DISCUSSION
MRP8 and MRP14 have predominantly been described as cytoplasmatic protein^.'*'^.'^*^^ In contrast, other members of the S-100 protein family show a clear association to membrane or cytoskeleton structures, eg, calpactin, S-100a/S-1008.2.'"22 We now show that the subcellular distribution of MRP8 and MRPI4 is Ca2+-dependent.
Using differential centrifugation, elevated levels of Ca2+ were found to lead to a translocation of these proteins from the cytoplasma to cytoskeletal and membrane fractions; the Ca2+ concentrations triggering translocation being in a physiological range ( IO-' to mol/L). As shown by addition of EGTA during washing procedures, Ca*+-dependent translocation appears to be reversible. These findings are in accordance with properties described for other S-l 00-like proteins, eg, calpactin and S-I OOa/S-1 OO@.2.18-22 However, S-IOOa/S-lOO@ have been shown to form disulfide bridges with their ligand 7-protein in a Ca2+-dependent manner. 37 In contrast, our data indicate that cystein residues of MRP8/MRP14 are not involved in binding to cytoskeletal and membrane structures.
Evidence for MRP8/MRP14 binding to the plasma membrane has been provided by Bhardwaj et al. 23 It was found that an epitope designated 27E10, which is constituted by the MRP8/MRP14 heterodimer. is accessible at the outer plasma membrane of A23 187-treated monocytes. Lemarchand et a138 reported recently that MRP8 is associated to the plasma membrane of A23 187-or zymosan-stimulated neutrophils. Additionally, they detected a protein band at 14 Kd which, because of apparent cross-reactivity of their aMRP8 antiserum, probably represents MRP14. However, the molecular mechanism of MRP8/MRPICbinding to membrane structures is not yet known. The failure of monensin to inhibit surface expression ofthe 27E10 epitope as well as the lack of leader sequences in MRP8 and MRP14 have suggested that these proteins do not follow the classical ER-Golgi route.'.'' Characteristic transmembrane domains have not been reported for MRP8 and MRP14 either.' Cross-linking membrane proteins of viable monocytes by DSS led to stabilization of MRP8/MRP14 complexes of25, 35, and 48 Kd. Their molecular weights are thus similar to those described earlier for cytosolic MRP8/MRP14.'3*'5.24 DSS treatment of viable cells did not lead to cross-linking of cytosolic proteins because, for example, LDH complexes were not linked by this procedure. The water-soluble analogue of DSS, BS3, could almost not stabilize membrane-associated MRP8/MRP14 complexes even when dissolved in DMSO, indicating that no appropriate lysin residues were accessible for cross-linking at the outer cell surface. We thus showed that complexed forms of MRP8/MRP14 are associated with plasma membranes of A23 187-treated monocytes. However, the quantitative ratio of MRP8 and MRPl4 in membrane-associated complexes should be viewed cautiously with respect to the applied method because the degree of covalent cross-linking depends on parameters such as the length of the cross-linker, the distance between different lysin residues, and effective concentrations of DSS and MRP8/MRP14 in the membrane.
To elucidate whether the MRP8/MRP14 complex preferentially binds via its MRP8 or via its MRPI4 subunit to either membranes or cytoskeleton, transfected L132 cells were studied. Our experiments showed that MRP8 as well as MRP14 can independently interact with membrane and cytoskeletal structures, thus indicating that association to these components does not necessarily require MRP8/ MRPl4 heteromer formation. Our biochemical data regarding Ca2+dependent association of MRP8 and MRP14 to the NP40-insoluble fraction of monocytes is in accordance with observations reported for keratinocytes by Kelly et Quantitative analysis showed that considerable amounts of MRP8 and MRP14 were translocated to membranes and cytoskeletal structures in a Ca2+-dependent manner. Interestingly, in the presence of Ca", higher amounts of MRP14 than of MRP8 were found to be associated with membranes, whereas MRP8 was quantitatively more detectable in the cytoskeletal fraction than MRPl4. These observations may reflect a preferential translocation of distinct MRP8/MRP14 complexes in vivo or may be due to different affinities of MRP8 and MRPI4 to subcellular structures. In previous studies, the existence of two isoforms of MRP14 has been reported that are both phosphorylated in a Ca'+-dependent manner.'5*".45 The question has to be raised whether various isoforms or phosphorylation states of MRPl4 may differ in their affinity to CaZ+, as recently described for calmodulin.46 and subsequently influence their interaction with specific intracellular ligands in distinct compartments.
MRP8/MRP14 complex formation has been reported to be Ca'+-depe~~dent.'~ Furthermore, MRP8/MRP I4 complexes rather than the monomers have been described to modulate kinase a~tivities.'~.'~ Therefore, it may be assumed that MRP8/MRP14 play a regulatory role for cytoskeleton/membrane interactions via phosphorylation events as has already been described for other members of the S-100 family, eg, pl I / c a l p a~t i n '~~~' *~~~~~ or S-~OOCU/~.'~~'~ Regarding phagocytes, such a modulatory effect of MRP8/MRP14 would be compatible with events associated with, for example, adherence, diapedesis, migration, and granule secretion. All of the latter are functions that coincide with activation of these cells. Expression of MRP8 and MRP14 by infiltrating neutrophils and monocytes has been supposed to reflect such an activation stage because both For personal use only. on October 3, 2017. by guest www.bloodjournal.org From proteins are abundant in infiltrating cells during a variety of inflammatory disorders in h u m a n~~p~*~. '~ as well as in models of expenmental inflammation in mice.',' Accordingly, membrane association of the MRP8/MRPl4 heterodimer was found to coincide with secretion of proinflammatory cytokines such as IL-1 and TNF-a by monocyte^,'^ and with activation of neutrophil^.^^ MRP8 and M R P 1 4 represent a major portion of the total cellular protein content in neutrophils and monocyte~'~-'~~"'" whereas mature macrophages do not contain these proteins at a l~'~'~* '~ Expression of MRP8/MRP14 in monocytes and neutrophils, therefore, reflects distinct cellular stages during myeloid differentiation that appear to be characterized by specific modes of reaction to Ca*+-mediated stimuli. Thus, differentiation-dependent expression of MRP8/MRP14 occurs in an analogous manner to that of other S-100-like protein^.^'.^^ Further insights concerning the specific role of MRP8/MRP14 for the modulation of membrane and cytoskeletal interactions may be of value for understanding the mechanisms underlying differentiation and activation of phagocytes.
